Research Topics
Genomes and GenesSpecies | Robert C BrunhamSummaryAffiliation: British Columbia Country: Canada Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Novel avian influenza H7N3 strain outbreak, British ColumbiaMartin Hirst
British Columbia Cancer Agency (BCCA) Genome Sciences Centre, Vancouver, British Columbia, Canada
Emerg Infect Dis 10:2192-5. 2004..This insertion likely occurred by recombination between the hemagglutination and matrix genes in the LPAI virus...
Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccineRobert C Brunham
University of British Columbia Centre for Disease Control, Vancouver, British Columbia V5Z 4R4, Canada
Nat Rev Immunol 5:149-61. 2005..In this review, we describe our current understanding of the immune response to infection with Chlamydia spp. and how this information is improving the prospects for development of a vaccine against infection with C. trachomatis...
Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunityXiaozhou Jiang
University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC V5Z 4R4, Canada
Infect Immun 76:2392-401. 2008..We conclude that the JAWS II cell line can substitute for primary BMDCs in Chlamydia immunobiological studies...
Parran Award Lecture: insights into the epidemiology of sexually transmitted diseases from Ro = betacDRobert C Brunham
UBC Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC V5Z 4R4
Sex Transm Dis 32:722-4. 2005
The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfectionRobert C Brunham
University of British Columbia Centre for Disease Control, Vancouver, Canada
J Infect Dis 192:1836-44. 2005..Since 1998, rates have increased, and case counts now exceed those recorded before the intervention...
Considerations on Chlamydia trachomatis disease expressionRobert C Brunham
University of British Columbia and British Columbia Centre for Disease Control, Vancouver, BC, Canada
FEMS Immunol Med Microbiol 55:162-6. 2009..Recent genomic, immunologic, and epidemiologic findings are reviewed. A synthesis is offered which suggests that Chlamydia disease expression results from persistent infection and host immune responses...
A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinctJose Rey-Ladino
University of British Columbia Centre for Disease Control, 655 West 12th Ave, Vancouver, BC V5Z 4R4, Canada
Infect Immun 73:1568-77. 2005..This result may explain in part the differences in protective immunity induced by natural infection and immunization with whole inactivated organisms and is relevant to rational chlamydia vaccine design strategies...
Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine modelsHong Yu
British Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, Canada
J Immunol 182:1602-8. 2009....
Survival of Chlamydia muridarum within dendritic cellsJose Rey Ladino
University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada
Infect Immun 75:3707-14. 2007..Together, these results raise the possibility that Chlamydia-infected DCs may be central to the maintenance of T-cell memory that underlies both immunity and immunopathology...
Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cellsHong Yu
British Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia V5Z 4R4, Canada
J Immunol 186:3615-21. 2011..muridarum. These insights should prove useful for improving vaccine design for Chlamydia trachomatis...
Chlamydia muridarum T-cell antigens formulated with the adjuvant DDA/TDB induce immunity against infection that correlates with a high frequency of gamma interferon (IFN-gamma)/tumor necrosis factor alpha and IFN-gamma/interleukin-17 double-positive CD4+ Hong Yu
British Columbia Centre for Disease Control, Vancouver, BC, Canada
Infect Immun 78:2272-82. 2010....
Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infectionXiaozhou Jiang
British Columbia Centre for Disease Control, University of British Columbia, Vancouver, BC, Canada
Immunology 129:556-66. 2010..muridarum pulmonary infection are associated with differences in early innate cytokine and cellular responses that are correlated with late differences in T helper type 17 versus type 1 adaptive immune responses...
Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirusRaymond H See
University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
J Gen Virol 87:641-50. 2006..Finally, the sera of vaccinated mice contained antibodies to S, further suggesting a role for this protein in conferring protective immunity against SARS-CoV infection...
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccinesRaymond H See
University of British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada
J Gen Virol 89:2136-46. 2008....
Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen ChlamydiaKaruna P Karunakaran
British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada
J Immunol 180:2459-65. 2008..The results provide evidence for lead vaccine candidates for a T cell-based subunit molecular vaccine against Chlamydia infection suitable for human study...
Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, CanadaDanuta M Skowronski
BC Centre for Disease Control, Vancouver, BC
CMAJ 176:47-53. 2007..In 2004 an outbreak of avian influenza of the H7N3 subtype occurred among poultry in British Columbia, Canada. We report compliance with recommended protective measures and associated human infections during this outbreak...
Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in miceHong Yu
British Columbia Centre for Disease Control, University of British Columbia, Vancouver, British Columbia, Canada
Infect Immun 80:1510-8. 2012..The T cell antigens and adjuvants discovered in this study are of further interest in the development of a molecularly defined Chlamydia vaccine...
Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profilesMichelle L Zaharik
University of British Columbia Centre for Disease Control, Vancouver, BC, Canada
Immunology 120:160-72. 2007..This has implications as to why early inactivated chlamydial vaccines were ineffective and suggests that new vaccine design efforts may benefit from in vitro DC screening for ELR chemokine expression profiles...
Modeling control strategies of respiratory pathogensBabak Pourbohloul
Division of Mathematical Modeling, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Emerg Infect Dis 11:1249-56. 2005..Contact network epidemiology can provide valuable quantitative input to public health decisionmaking, even before a pathogen is well characterized...
Longitudinal analysis of genotype distribution of influenza A virus from 2003 to 2005Annie Mak
BC Centre for Disease Control, 655 W12th Ave, Vancouver, BC V5Z 4R4, Canada
J Clin Microbiol 44:3583-8. 2006..Our findings indicate that genotype determination promises to be a rapid approach for detecting new strains of influenza A viruses in a population...
GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatisHang Lu
British Columbia Center for Disease Control and Department of Medicine, University of British Columbia, Vancouver, Canada
J Immunol 169:6324-31. 2002..In aggregate, the findings demonstrate that the local cytokine environment is critical to the induction of protective immunity following chlamydial vaccination and that GM-CSF may be a useful adjuvant for a chlamydial vaccine...
Development of a Chlamydia trachomatis T cell VaccineKaruna P Karunakaran
British Columbia Centre for Disease Control, Vancouver, B C, Canada
Hum Vaccin 6:676-80. 2010..This review mainly focuses on an immunoproteomic approach used in our laboratory to identify Chlamydia T cell antigens and how these T cell antigens can be developed into a future human Chlamydia vaccine...
Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced ageDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, BC, V5Z 4R4, Canada
J Infect Dis 203:158-67. 2011..Pandemic H1N1 (pH1N1) surveillance data showed lower attack rates but higher risk of severe outcomes with advanced age. We explored immuno-epidemiologic correlates of surveillance findings including humoral and cell-mediated immunity (CMI)...
Impact of mass treatment on syphilis transmission: a mathematical modeling approachBabak Pourbohloul
University of British Columbia Centre for Disease Control, Vancouver, Canada
Sex Transm Dis 30:297-305. 2003..By 1 year postintervention, syphilis cases had rebounded significantly. We investigate the cause of this postintervention rebound...
Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsiaPeter von Dadelszen
Department of Obstetrics and Gynaecology, Children s and Women s Health Centre of British Columbia, University of British Columbia, 2H30 4500 Oak Street, Vancouver, BC, Canada V6H 3N1
BJOG 110:725-30. 2003..Could reactivated chronic infection be both a trigger for these differential maternal responses to the same underlying pathology and a link between pre-eclampsia and its attendant lifelong risks of atherosclerosis?..
Whole-genome sequencing and social-network analysis of a tuberculosis outbreakJennifer L Gardy
British Columbia Centre for Disease Control, Vancouver, BC, Canada
N Engl J Med 364:730-9. 2011..Traditional contact tracing did not identify a source. We used whole-genome sequencing and social-network analysis in an effort to describe the outbreak dynamics at a higher resolution...
Rapid response research to emerging infectious diseases: lessons from SARSB Brett Finlay
Biotechnology Laboratory and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
Nat Rev Microbiol 2:602-7. 2004
Molecular analysis of the multiple GroEL proteins of ChlamydiaeKaruna P Karunakaran
University of British Columbia Centre for Disease Control. Genome Sequence Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
J Bacteriol 185:1958-66. 2003..coli groEL mutant. Complementation did not occur with groEL2 or groEL3 alone or together with groES. The role for each of the three GroELs in the chlamydial developmental cycle and in disease pathogenesis requires further study...
Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everythingJessica M Conway
Division of Mathematical Modeling, University of British Columbia Centre for Disease Control, 655 West 12th Avenue, V5Z 4R4 Vancouver, British Columbia, Canada
BMC Public Health 11:932. 2011..We adapted a city-level contact network model to study different campaigns on influenza morbidity and mortality...
Coordinated response to SARS, Vancouver, CanadaDanuta M Skowronski
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Emerg Infect Dis 12:155-8. 2006..Baseline preparedness for pandemic threats may account for the absence of sustained transmission and fewer cases of SARS in Vancouver...
Needs, gaps and opportunities for infectious disease research in British Columbia: a perspective from population and public healthDavid M Patrick
University of British Columbia, British Columbia Centre for Disease Control, Vancouver, BC
Can J Public Health 97:S24-32, S27-36. 2006..A review of infectious disease research activity and capacity was performed in British Columbia and linked to a process for identifying needs, gaps and opportunities from a public health perspective...
Mapping the protein interaction network in methicillin-resistant Staphylococcus aureusArtem Cherkasov
Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
J Proteome Res 10:1139-50. 2011..Thus, this empirical MRSA-252 PIN provides a rich source for identifying critical proteins essential for network stability, many of which can be considered as prospective antimicrobial drug targets...
Severe acute respiratory syndrome (SARS): a year in reviewDanuta M Skowronski
University of British Columbia Center for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4
Annu Rev Med 56:357-81. 2005..This review synthesizes lessons learned from this remarkable achievement. These lessons can be applied to re-emergence of SARS or to the next pandemic threat to arise...
Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancyMichael L Rekart
School of Population and Public Health, University of British Columbia, Vancouver, Canada
J Infect Dis 207:30-8. 2013....
Time evolution of epidemic disease on finite and infinite networksPierre André Noël
University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada V5Z 4R4
Phys Rev E Stat Nonlin Soft Matter Phys 79:026101. 2009..This formalism can be equally applied to similar percolation phenomena on networks in other areas of science and technology...
Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from CanadaDanuta M Skowronski
University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC, Canada V5Z 4R4
Vaccine 24:4222-32. 2006..We assess cost-effectiveness of this program in Canada...
Structural characterization of genomes by large scale sequence-structure threading: application of reliability analysis in structural genomicsArtem Cherkasov
Division of Infectious Diseases, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
BMC Bioinformatics 5:101. 2004..For instance, Weibull distributions are widely used in reliability, maintainability and safety work to model time-to-failure of mechanical devices, mechanisms, building constructions and equipment...
Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North AmericaBabak Pourbohloul
Division of Mathematical Modeling, British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Influenza Other Respi Viruses 3:215-22. 2009..We determined the reproduction number of pandemic (H1N1) 2009 by analyzing the dynamics of the complete case series in Mexico City during this early period...
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from CanadaDanuta M Skowronski
British Columbia Centre for Disease Control BCCDC, Vancouver, British Columbia, Canada
PLoS Med 7:e1000258. 2010..Several epidemiologic investigations were conducted through the summer to assess this putative association...
Targeted mass treatment for syphilis with oral azithromycinMichael L Rekart
University of British Columbia Centre for Disease Control, Canada
Lancet 361:313-4. 2003..0001<p<0.0044). This rate rebound and the absence of a sustained effect suggest that targeted mass treatment for syphilis, even though feasible, should not be done routinely...
Identification of pyruvate kinase in methicillin-resistant Staphylococcus aureus as a novel antimicrobial drug targetRoya Zoraghi
Department of Medicine, Centre for High Throughput Biology, University of British Columbia, Vancouver, British Columbia, Canada
Antimicrob Agents Chemother 55:2042-53. 2011....
International health: five reasons why Canadians should get involvedMichael L Rekart
University of British Columbia Centre for Disease Control, 655 West 12th Avenue, Vancouver, BC V5Z 4R4
Can J Public Health 94:258-9. 2003
Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?Danuta M Skowronski
University of British Columbia Centre for Disease Control, Epidemiology Services, Vancouver, British Columbia, Canada
J Infect Dis 187:495-9. 2003..Although vaccinated ORS-affected individuals had less of a type 1 basis than did vaccinated unaffected individuals, this difference was not statistically significant...
Effect of immune response on transmission dynamics for sexually transmitted infectionsSuvendrini Lena
University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
J Infect Dis 191:S78-84. 2005..Elucidation of the immunobiological and behavioral factors that shape STI transmission should inform better STI prevention and control programs...
Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1)Karuna P Karunakaran
University of British Columbia Centre for Disease Control, Vancouver, Canada
J Clin Microbiol 40:4010-4. 2002..9; 95% confidence interval, 1.1 to 175). Our studies indicate that phage-containing strains of C. pneumoniae are uncommonly found by isolation but may commonly infect individuals with vascular disease...
Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity?Oliver P Günther
University of British Columbia Centre for Disease Control, Vancouver, British Columbia
J Infect Dis 197:1653-61. 2008..There is strong evidence that human papillomavirus (HPV) is necessary for the development of cervical cancer. A prophylactic HPV vaccine with high reported efficacy was approved in North America in 2006...
Neisseria meningitidis carriage during an outbreak of serogroup C diseaseDavid M Patrick
Communicable Disease Epidemiology, University of British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
Clin Infect Dis 37:1183-8. 2003....
The Genome sequence of the SARS-associated coronavirusMarco A Marra
British Columbia Cancer Agency BCCA Genome Sciences Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada
Science 300:1399-404. 2003....
Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse modelShawn Babiuk
Vaccine and Infectious Disease Organization, Saskatoon, SK, Canada
J Med Virol 72:138-42. 2004..We confirm that vaccine aggregates deviate the immune response to a greater Th2 cytokine pattern with potential implications for vaccine screening, safety, and efficacy...
Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon- gammaCraig R Cohen
Department of Obstetrics, Gynecology, and Reproductive Science, University of California, San Francisco, San Francisco, California 94105, USA
J Infect Dis 192:591-9. 2005..This investigation supports a direct role for C. trachomatis-specific immune responses in altering the risk of infection and suggests immune correlates of protection that are potentially useful in vaccine development...
Immunogenetic correlates for Chlamydia trachomatis-associated tubal infertilityCraig R Cohen
Departments of Obstetrics and Gynecology, University of Washington, Box 356460, Seattle, WA 98195, USA
Obstet Gynecol 101:438-44. 2003..To understand immunogenetic mechanisms of Chlamydia trachomatis infection and tubal scarring...
Network theory and SARS: predicting outbreak diversityLauren Ancel Meyers
Section of Integrative Biology and Institute for Cellular and Molecular Biology, University of Texas at Austin, 1 University Station C0930, Austin, TX 78712, USA
J Theor Biol 232:71-81. 2005..We offer quantitative insight into the heterogeneity of SARS outbreaks worldwide, and illustrate the utility of this approach for assessing public health strategies...
Identification of severe acute respiratory syndrome in CanadaSusan M Poutanen
Toronto Medical Laboratories and Mount Sinai Hospital Department of Microbiology, Toronto, Canada
N Engl J Med 348:1995-2005. 2003..It appears to be of viral origin, with patterns suggesting droplet or contact transmission. The role of human metapneumovirus, a novel coronavirus, or both requires further investigation...
The arrested immunity hypothesis and the epidemiology of chlamydia controlRobert C Brunham
Sex Transm Dis 35:53-4. 2008
Associations among human leukocyte antigen (HLA) class II DQ variants, bacterial sexually transmitted diseases, endometritis, and fertility among women with clinical pelvic inflammatory diseaseRoberta B Ness
Graduate School of Public Health and Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Sex Transm Dis 31:301-4. 2004..We investigated associations between HLA class II DQ alleles, chlamydial and gonococcal cervicitis, endometritis, and infertility among women with pelvic inflammatory disease (PID)...
Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) StudyRoberta B Ness
Department of Epidemiology, University of Pittsburgh, PA 15261, USA
Sex Transm Dis 35:129-35. 2008..Among women with pelvic inflammatory disease (PID), we assessed the associations among antibodies to Chlamydia trachomatis elementary bodies (EB), antibodies to chlamydia heat shock protein (Chsp60), rates of pregnancy, and PID recurrence...
Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancerRoberta B Ness
Graduate School of Public Health and Pittsburgh Cancer Institute, University of Pittsburgh, 130 DeSoto Street, 517 Parran Hall, Pittsburgh, PA 15261, USA
J Infect Dis 187:1147-52. 2003..09) in ovarian cancer risk associated with CHSP60-1 but not with CHSP60-2, CHSP60-3, or CHSP10. These data suggest that past or chronic persistent infection with chlamydia may be a risk factor for ovarian cancer...
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccineAlexander N Zakhartchouk
Vaccine and Infectious Disease Organization VIDO, University of Saskatchewan, 120 Veterinary Road, Saskatoon, Sask, Canada S7N 5E3
Vaccine 25:136-43. 2007..This finding suggests that carbohydrate is important for the immunogenicity of the S318-510 protein fragment and provide useful information for designing an effective and safe SARS subunit vaccine...
Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancerJorma Paavonen
Department of Obstetrics and Gynecology, University of Helsinki, Haartmaninkatu 2, 00290 Helsinki, Finland
Am J Obstet Gynecol 189:1287-92. 2003..The purpose of this study was to determine whether serum antibody response to the three versions of chlamydial heat shock protein 60 is associated with an increased risk for cervical cancer...
Evidence that plant-like genes in Chlamydia species reflect an ancestral relationship between Chlamydiaceae, cyanobacteria, and the chloroplastFiona S L Brinkman
Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada, V5A 1S6
Genome Res 12:1159-67. 2002....
Sexually transmitted disease thresholds in Manitoba, CanadaAnn M Jolly
University of Manitoba, Winnipeg, Manitoba
Ann Epidemiol 15:781-8. 2005..We hypothesized that people with repeated bacterial STI's and their sex partners include the theoretical core group and that they differ from singly infected noncore individuals...
Research Grants
- Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell ImmunoprotemicsRobert Brunham; Fiscal Year: 2009..In this proposal a novel immunoproteomic approach is described based on identifying Chlamydia peptides capable of producing protective cellular immunity that shows great promise towards the development of a Chlamydia vaccine. ..
- Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell ImmunoprotemicsLeonard J Foster; Fiscal Year: 2010..In this proposal a novel immunoproteomic approach is described based on identifying Chlamydia peptides capable of producing protective cellular immunity that shows great promise towards the development of a Chlamydia vaccine. ..
